A variety of FePt nanocrystals, including nanowires, nanorods, nanocubes, and nanosized DNA Damage inhibitor multipods, were successfully obtained. The shape control was realized by simply varying synthesis
parameters. The as-synthesized nanocrystals, having chemically disordered fcc structure, are found to be superparamagnetic at room temperature and their ferromagnetic-superparamagnetic transition temperature is size dependent that increases with particle size. The as-synthesized FePt nanocrystals were transformed to the chemically ordered L1(0) structure upon heat treatment, which exhibits hard magnetic properties with coercivity as high as 25 kOe. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3077210]“
“The redox properties of the hydroethanol extract
(EE) and its ethyl acetate (EAF) and hydromethanol (HMF) fractions obtained from Abarema cochliacarpos (Gomes) Barneby & Grimes stem bark were evaluated. EAF had the highest total phenol content (848.62 +/- 78.18mgg(-1)), while EE showed the highest content of catechin (71.2 mu gg(-1)). EE, EAF and HMF exhibited the highest levels of antioxidant find more activity at 100 and 1000 mu gmL(-1) when the non-enzymatic antioxidant potential was evaluated by the total reactive antioxidant potential, total antioxidant reactivity and nitric oxide scavenging assays. In addition, EAF and HMF showed SOD-like activity. The results for EE, EAF and HMF in this study showed that A. cochliacarpos (Gomes) Barneby & Grimes stem bark have redox properties and may be able to help the endogenous enzymatic and non-enzymatic systems to keep the redox balance.”
“To assess the patterns of, and trends over time in, health-related
quality of life (HRQL) reporting in randomized controlled trials (RCTs).
The English-language literature of RCTs published in 2002-2008 was identified using Medline, Embase, and Healthstar Taselisib inhibitor databases, in addition to the Cochrane Clinical Trials Registry. Eligible trials were phase III studies that included an HRQL outcome. Data were abstracted on eight outcomes derived from previously recommended quality standards for reporting HRQL, and on four outcomes describing how HRQL data are presented in RCT reports. Two readers examined each article; discrepancies were resolved through discussion and third review if required.
A sample of 794 RCTs was identified. HRQL was a primary outcome in 25.4% (200/794). One hundred and ten RCTs (14%) used “”supplementary”" reports (separate from the first publication) to report HRQL findings. The proportion of RCTs that met the eight quality indicators ranged from 15% (HRQL used in the calculation of sample size) to 81% (reporting instrument validity). RCTs with HRQL as a primary outcome or with a supplementary report had higher concordance on the quality measures. Reporting improved on many indicators over time. Substantive variation in how HRQL data are presented in RCTs was evident.